Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
STIP1 is an adaptor protein that coordinates the functions of HSP70 (see HSPA1A\; MIM 140550) and HSP90 (see HSP90AA1\; MIM 140571) in protein folding. Additionally we are shipping Stress-Induced-phosphoprotein 1 Proteins (21) and Stress-Induced-phosphoprotein 1 Kits (10) and many more products for this protein.
Showing 10 out of 135 products:
Human Monoclonal STIP1 Primary Antibody for FACS, IF - ABIN524365
Wang, Chao, Tsai, Chang, Chen, Lee, Chen, Lin, Chang, Wang, Chao, Chang, Chang, Lai, Wang: Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. in Molecular & cellular proteomics : MCP 2010
Show all 3 Pubmed References
Human Monoclonal STIP1 Primary Antibody for IF, IHC (p) - ABIN564756
Ho, Kong, Choong, Loh, Toy, Chong, Wong, Wong, Shah, Lim: Novel breast cancer metastasis-associated proteins. in Journal of proteome research 2009
Show all 3 Pubmed References
Human Polyclonal STIP1 Primary Antibody for FACS, IHC (p) - ABIN1882135
Onuoha, Coulstock, Grossmann, Jackson: Structural studies on the co-chaperone Hop and its complexes with Hsp90. in Journal of molecular biology 2008
Show all 2 Pubmed References
Human Monoclonal STIP1 Primary Antibody for IF, IHC (p) - ABIN564757
Footz, Johnson, Dubois, Boivin, Raymond, Walter: Glaucoma-associated WDR36 variants encode functional defects in a yeast model system. in Human molecular genetics 2009
Human Monoclonal STIP1 Primary Antibody for IF, ELISA - ABIN950133
Tsai, Tsai, Lin, Chen, Lee, Chao, Wang, Wang, Lai: Secreted stress-induced phosphoprotein 1 activates the ALK2-SMAD signaling pathways and promotes cell proliferation of ovarian cancer cells. in Cell reports 2012
In conclusion, STIP1 is upregulated in HCC (show FAM126A Antibodies) and associated with poor clinical prognosis. Blocking STIP1 activity suppresses HCC (show FAM126A Antibodies) cell growth, providing the rationale for STIP1 as a potential therapeutic target in HCC (show FAM126A Antibodies).
Domains of STIP1 responsible for regulating PrPC (show PRNP Antibodies)-dependent amyloid-beta oligomer toxicity
Reduced STIP1 levels can contribute to phenotypes related to hyperactivity and attention deficits.
We correlate the expression of STI1 and glioma progression, and suggest that STI1 expression in microglia/macrophages and infiltrating lymphocytes is modulated by the brain tumor microenvironment.
Knockdown of PIAS1 (show PIAS1 Antibodies) in astrocytes impairs the accumulation of nuclear STI1 in response to irradiation. Moreover, a PIAS1 (show PIAS1 Antibodies) mutant lacking the STI1 binding site is unable to increase STI1 nuclear retention.
stress-inducible protein-1 has a role in recruitment of bone marrow derived cells into the ischemic brains
Our findings reveal a previously unrecognized role of the PrP(C (show PRNP Antibodies)) ligand STI1 in protecting neurons in Alzheimer disease and suggest a novel pathway that may help to offset AbetaO-induced toxicity.
Stress-inducible phosphoprotein 1 has unique cochaperone activity during development and regulates cellular response to ischemia via the prion protein (show PRNP Antibodies).
STI1 and laminin-gamma1 promote robust axonogenesis in wild-type dorsal root ganglia neurons; STI1 promotes extracellular calcium influx.
Neuroprotection and neuritogenesis mediated by PrP(C (show PRNP Antibodies))-STI1 engagement are dependent upon the increased protein synthesis mediated by PI3K-mTOR (show FRAP1 Antibodies) signaling.
Significant genetic association was identified at the rs2236647 (T/C) SNP in STIP1 and risk of asthma (p < 0.001). The C allele and CC genotype of this SNP were significantly higher in asthmatics compared with controls.
Functional studies showed that STIP1 promoted the growth, colony formation and migration of cancer cells. However, knocking down the expression of STIP1 inhibited the growth, colony formation and migration of cancer cells.
In vitro experiments revealed that STIP1 was capable of binding to the MMP-9 (show MMP9 Antibodies) promoter and enhanced its transcriptional expression
STIP1 modulates the function of the HSP90 (show HSP90 Antibodies)-JAK2 (show JAK2 Antibodies)-STAT3 (show STAT3 Antibodies) complex
Hsp70/Hsp90-organizing protein promoter activity was highest in Hs578T which expressed mutant or inactive p53 (show TP53 Antibodies). HRAS (show HRAS Antibodies) activation of the Hsp70/Hsp90-organizing protein promoter was inhibited by p53 (show TP53 Antibodies) overexpression.
the modulation of HOP-PrP(C (show PRNP Antibodies)) engagement or the decrease of PrP(C (show PRNP Antibodies)) and HOP expression may represent a potential therapeutic intervention in glioblastoma.
Data suggest that calcium signaling plays important role in prevention of protein misfolding; complexes of S100A1 (show S100A1 Antibodies) and STIP1 are key players in this pathway; the stoichiometry of S100A1 (show S100A1 Antibodies)/STIP1 interaction appears to be three S100A1 (show S100A1 Antibodies) dimers plus one STIP1 monomer; each S100A1 (show S100A1 Antibodies)-STIP1-binding interaction is entropically driven. (S100A1 (show S100A1 Antibodies) = S100 calcium binding protein A1 (show S100A1 Antibodies); STIP1 = stress-induced-phosphoprotein 1) [REVIEW]
Results indicte the great potential of STIP1 (stress-induced phosphoprotein 1) as a biomarker and therapeutic target in renal cell carcinoma (show MOK Antibodies) (RCC (show XRCC1 Antibodies)) bone metastasis.
Data suggest that three dimers of S100A1 (S100 calcium binding protein A1 (show S100A1 Antibodies)) associate with one molecule of STIP1 (stress-inducible phosphoprotein 1) in a calcium-dependent manner; individual STIP1 TPR (tetratricopeptide repeat) domains, TPR1, TPR2A and TPR2B, bind a single S100A1 (show S100A1 Antibodies) dimer with significantly different affinities; TPR2B domain possesses highest affinity for S100A1 (show S100A1 Antibodies).
STIP1 is an adaptor protein that coordinates the functions of HSP70 (see HSPA1A\; MIM 140550) and HSP90 (see HSP90AA1\; MIM 140571) in protein folding. It is thought to assist in the transfer of proteins from HSP70 to HSP90 by binding both HSP90 and substrate-bound HSP70. STIP1 also stimulates the ATPase activity of HSP70 and inhibits the ATPase activity of HSP90, suggesting that it regulates both the conformations and ATPase cycles of these chaperones (Song and Masison, 2005
, NY-REN-11 antigen
, hsc70/Hsp90-organizing protein
, renal carcinoma antigen NY-REN-11
, transformation-sensitive protein IEF SSP 3521
, Hsp70/Hsp90 organizing protein
, IEF SSP 3521
, stress-induced-phosphoprotein 1
, stress-inducible protein
, stress-induced-phosphoprotein 1 (Hsp70/Hsp90-organizing protein)
, Stress-induced-phosphoprotein 1
, Hsc70/Hsp90-organizing protein